Hi all. Long time holder, I dont post often, sometimes I drop in to read what the general sentiment is
I'm completely at a loss about AC8 right now. I can accept that the company didnt really have any direction, the hard-shell capsule thing was a huge waste of time, Ido was a waste of time... fine I accept all that, we had cash in the bank, enough to possibly turn things around...
I'm trying to understand what has been said to Nick Woolf, who I can only assume has a reasonable level of intelligence, HOW has he been convinced that spending $17.5m on this company is the way to go?
I'm actaully asking? Any CP1 holders here, please explain it to me
1) Whats so special about CP1's product?
2) Is there even an appetite for cannabis treatments for dogs? And whats the estimates market share value
3) Let's assume everything goes to plan, how long before break-even on the $17.5 m?
You can ignore me, you can tell me to DYOR... but I have, & I am bewildered.... I dont get it. I feel like I've been scammed
I really want to be assured that this is a reasonable bet... but I'm looking at this whole thing and genuinely shocked at the level of apparent incompetence...
I reckon I could have run this company better...
- Forums
- ASX - By Stock
- AC8
- Ann: CannPal and AusCann Enter into Scheme of Arrangement
Ann: CannPal and AusCann Enter into Scheme of Arrangement, page-74
Featured News
Add AC8 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online